Pharmarise Holdings Corporation (TYO:2796)

Pharmarise Holdings Balance Sheet

Financials in millions JPY. Fiscal year is June - May.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Cash & Equivalents	2,941	6,012	4,911	7,150	4,742	3,991
Cash & Short-Term Investments	2,941	6,012	4,911	7,150	4,742	3,991
Cash Growth	38.46%	22.42%	-31.31%	50.78%	18.82%	-13.31%
Accounts Receivable	1,324	1,107	735	1,439	605	479
Other Receivables	3,111	2,638	3,050	2,117	3,412	3,786
Receivables	4,435	3,745	3,785	3,556	4,017	4,265
Inventory	3,726	2,812	4,146	2,645	2,290	2,302
Other Current Assets	883	595	397	386	323	320
Total Current Assets	11,985	13,164	13,239	13,737	11,372	10,878
Property, Plant & Equipment	7,677	7,621	7,209	6,198	6,010	6,355
Long-Term Investments	-	2,637	2,484	2,296	2,008	2,139
Goodwill	7,044	7,257	6,800	5,917	2,748	3,220
Other Intangible Assets	313	345	466	502	502	409
Long-Term Deferred Tax Assets	-	1,652	1,723	834	778	741
Long-Term Deferred Charges	-	-	-	-	-	1
Other Long-Term Assets	4,202	1	2	2	2	2
Total Assets	31,221	32,680	31,924	29,486	23,421	23,746

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Accounts Payable	7,015	6,627	6,647	5,690	4,252	4,109
Accrued Expenses	324	885	893	903	805	708
Current Portion of Long-Term Debt	4,663	4,781	2,639	2,655	3,490	2,276
Current Portion of Leases	-	144	158	176	187	214
Current Income Taxes Payable	114	347	284	286	333	429
Other Current Liabilities	1,273	1,226	1,367	978	768	741
Total Current Liabilities	13,389	14,010	11,988	10,688	9,835	8,477
Long-Term Debt	9,167	9,810	11,053	9,654	5,216	7,085
Long-Term Leases	-	417	429	264	245	337
Pension & Post-Retirement Benefits	1,070	1,054	1,038	941	791	781
Other Long-Term Liabilities	940	531	500	499	349	368
Total Liabilities	24,566	25,822	25,008	22,046	16,436	17,048

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Common Stock	1,961	1,961	1,961	1,961	1,298	1,274
Additional Paid-In Capital	2,091	2,091	2,186	2,177	1,553	1,529
Retained Earnings	2,697	2,893	2,938	3,530	4,014	3,811
Treasury Stock	-376	-376	-471	-550	-210	-210
Comprehensive Income & Other	267	272	253	242	225	203
Total Common Equity	6,640	6,841	6,867	7,360	6,880	6,607
Minority Interest	15	17	49	80	105	91
Shareholders' Equity	6,655	6,858	6,916	7,440	6,985	6,698
Total Liabilities & Equity	31,221	32,680	31,924	29,486	23,421	23,746

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Total Debt	13,830	15,152	14,279	12,749	9,138	9,912
Net Cash (Debt)	-10,889	-9,140	-9,368	-5,599	-4,396	-5,921
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-910.80	-766.78	-827.45	-532.02	-352.52	-477.64
Filing Date Shares Outstanding	11.5	11.5	11.36	11.24	9.43	9.35
Total Common Shares Outstanding	11.5	11.5	11.36	11.24	9.43	9.35
Working Capital	-1,404	-846	1,251	3,049	1,537	2,401
Book Value Per Share	577.26	594.74	604.44	654.62	729.93	706.43
Tangible Book Value	-717	-761	-399	941	3,630	2,978
Tangible Book Value Per Share	-62.33	-66.16	-35.12	83.69	385.12	318.41

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error